Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking
Although stress has profound effects on motivated behavior, the underlying mechanisms responsible are incompletely understood. In this study we elucidate a functional pathway in mouse brain that encodes the aversive effects of stress and mediates stress-induced reinstatement of cocaine place prefere...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 106; no. 45; pp. 19168 - 19173 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
10.11.2009
National Acad Sciences |
Subjects | |
Online Access | Get full text |
ISSN | 0027-8424 1091-6490 1091-6490 |
DOI | 10.1073/pnas.0910705106 |
Cover
Abstract | Although stress has profound effects on motivated behavior, the underlying mechanisms responsible are incompletely understood. In this study we elucidate a functional pathway in mouse brain that encodes the aversive effects of stress and mediates stress-induced reinstatement of cocaine place preference (CPP). Activation of the dynorphin/kappa opioid receptor (KOR) system by either repeated stress or agonist produces conditioned place aversion (CPA). Because KOR inhibition of dopamine release in the mesolimbic pathway has been proposed to mediate the dysphoria underlying this response, we tested dopamine-deficient mice in this study and found that KOR agonist in these mice still produced CPA. However, inactivation of serotonergic KORs by injection of the KOR antagonist norBNI into the dorsal raphe nucleus (DRN), blocked aversive responses to the KOR agonist U50,488 and blocked stress-induced reinstatement of CPP. KOR knockout (KO) mice did not develop CPA to U50,488; however, lentiviral re-expression of KOR in the DRN of KOR KO mice restored place aversion. In contrast, lentiviral expression in DRN of a mutated form of KOR that fails to activate p38 MAPK required for KOR-dependent aversion, did not restore place aversion. DRN serotonergic neurons project broadly throughout the brain, but the inactivation of KOR in the nucleus accumbens (NAc) coupled with viral re-expression in the DRN of KOR KO mice demonstrated that aversion was encoded by a DRN to NAc projection. These results suggest that the adverse effects of stress may converge on the serotonergic system and offers an approach to controlling stress-induced dysphoria and relapse. |
---|---|
AbstractList | Although stress has profound effects on motivated behavior, the underlying mechanisms responsible are incompletely understood. In this study we elucidate a functional pathway in mouse brain that encodes the aversive effects of stress and mediates stress-induced reinstatement of cocaine place preference (CPP). Activation of the dynorphin/kappa opioid receptor (KOR) system by either repeated stress or agonist produces conditioned place aversion (CPA). Because KOR inhibition of dopamine release in the mesolimbic pathway has been proposed to mediate the dysphoria underlying this response, we tested dopamine-deficient mice in this study and found that KOR agonist in these mice still produced CPA. However, inactivation of serotonergic KORs by injection of the KOR antagonist norBNI into the dorsal raphe nucleus (DRN), blocked aversive responses to the KOR agonist U50,488 and blocked stress-induced reinstatement of CPP. KOR knockout (KO) mice did not develop CPA to U50,488; however, lentiviral re-expression of KOR in the DRN of KOR KO mice restored place aversion. In contrast, lentiviral expression in DRN of a mutated form of KOR that fails to activate p38 MAPK required for KOR-dependent aversion, did not restore place aversion. DRN serotonergic neurons project broadly throughout the brain, but the inactivation of KOR in the nucleus accumbens (NAc) coupled with viral re-expression in the DRN of KOR KO mice demonstrated that aversion was encoded by a DRN to NAc projection. These results suggest that the adverse effects of stress may converge on the serotonergic system and offers an approach to controlling stress-induced dysphoria and relapse. Although stress has profound effects on motivated behavior, the underlying mechanisms responsible are incompletely understood. In this study we elucidate a functional pathway in mouse brain that encodes the aversive effects of stress and mediates stress-induced reinstatement of cocaine place preference (CPP). Activation of the dynorphin/kappa opioid receptor (KOR) system by either repeated stress or agonist produces conditioned place aversion (CPA). Because KOR inhibition of dopamine release in the mesolimbic pathway has been proposed to mediate the dysphoria underlying this response, we tested dopamine-deficient mice in this study and found that KOR agonist in these mice still produced CPA. However, inactivation of serotonergic KORs by injection of the KOR antagonist norBNI into the dorsal raphe nucleus (DRN), blocked aversive responses to the KOR agonist U50,488 and blocked stress-induced reinstatement of CPP. KOR knockout (KO) mice did not develop CPA to U50,488; however, lentiviral re-expression of KOR in the DRN of KOR KO mice restored place aversion. In contrast, lentiviral expression in DRN of a mutated form of KOR that fails to activate p38 MAPK required for KOR-dependent aversion, did not restore place aversion. DRN serotonergic neurons project broadly throughout the brain, but the inactivation of KOR in the nucleus accumbens (NAc) coupled with viral re-expression in the DRN of KOR KO mice demonstrated that aversion was encoded by a DRN to NAc projection. These results suggest that the adverse effects of stress may converge on the serotonergic system and offers an approach to controlling stress-induced dysphoria and relapse. [PUBLICATION ABSTRACT] Although stress has profound effects on motivated behavior, the underlying mechanisms responsible are incompletely understood. In this study we elucidate a functional pathway in mouse brain that encodes the aversive effects of stress and mediates stress-induced reinstatement of cocaine place preference (CPP). Activation of the dynorphin/kappa opioid receptor (KOR) system by either repeated stress or agonist produces conditioned place aversion (CPA). Because KOR inhibition of dopamine release in the mesolimbic pathway has been proposed to mediate the dysphoria underlying this response, we tested dopamine-deficient mice in this study and found that KOR agonist in these mice still produced CPA. However, inactivation of serotonergic KORs by injection of the KOR antagonist norBNI into the dorsal raphe nucleus (DRN), blocked aversive responses to the KOR agonist U50,488 and blocked stress-induced reinstatement of CPP. KOR knockout (KO) mice did not develop CPA to U50,488; however, lentiviral re-expression of KOR in the DRN of KOR KO mice restored place aversion. In contrast, lentiviral expression in DRN of a mutated form of KOR that fails to activate p38 MAPK required for KOR-dependent aversion, did not restore place aversion. DRN serotonergic neurons project broadly throughout the brain, but the inactivation of KOR in the nucleus accumbens (NAc) coupled with viral re-expression in the DRN of KOR KO mice demonstrated that aversion was encoded by a DRN to NAc projection. These results suggest that the adverse effects of stress may converge on the serotonergic system and offers an approach to controlling stress-induced dysphoria and relapse.Although stress has profound effects on motivated behavior, the underlying mechanisms responsible are incompletely understood. In this study we elucidate a functional pathway in mouse brain that encodes the aversive effects of stress and mediates stress-induced reinstatement of cocaine place preference (CPP). Activation of the dynorphin/kappa opioid receptor (KOR) system by either repeated stress or agonist produces conditioned place aversion (CPA). Because KOR inhibition of dopamine release in the mesolimbic pathway has been proposed to mediate the dysphoria underlying this response, we tested dopamine-deficient mice in this study and found that KOR agonist in these mice still produced CPA. However, inactivation of serotonergic KORs by injection of the KOR antagonist norBNI into the dorsal raphe nucleus (DRN), blocked aversive responses to the KOR agonist U50,488 and blocked stress-induced reinstatement of CPP. KOR knockout (KO) mice did not develop CPA to U50,488; however, lentiviral re-expression of KOR in the DRN of KOR KO mice restored place aversion. In contrast, lentiviral expression in DRN of a mutated form of KOR that fails to activate p38 MAPK required for KOR-dependent aversion, did not restore place aversion. DRN serotonergic neurons project broadly throughout the brain, but the inactivation of KOR in the nucleus accumbens (NAc) coupled with viral re-expression in the DRN of KOR KO mice demonstrated that aversion was encoded by a DRN to NAc projection. These results suggest that the adverse effects of stress may converge on the serotonergic system and offers an approach to controlling stress-induced dysphoria and relapse. |
Author | Chavkin, Charles Schattauer, Selena Giardino, William J Messinger, Daniel Land, Benjamin B Aita, Megumi Hnasko, Thomas S Palmiter, Richard D Bruchas, Michael R |
Author_xml | – sequence: 1 fullname: Land, Benjamin B – sequence: 2 fullname: Bruchas, Michael R – sequence: 3 fullname: Schattauer, Selena – sequence: 4 fullname: Giardino, William J – sequence: 5 fullname: Aita, Megumi – sequence: 6 fullname: Messinger, Daniel – sequence: 7 fullname: Hnasko, Thomas S – sequence: 8 fullname: Palmiter, Richard D – sequence: 9 fullname: Chavkin, Charles |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19864633$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkktv1DAUhSNURKeFNSvA6gZYTGvH8WuDVFW8pEosoGvLSW6mnmbs1HZG9Bfwt3Fmhg50URZRYp3vHp_Y56g4cN5BUbwk-JRgQc8GZ-IpVvkbM4L5k2JG8mrOK4UPihnGpZjLqqwOi6MYlxhjxSR-VhwSJXnFKZ0Vv86bZNcmWe-Q71C6BnRjhsEgP1hvWxSggSH5gKzbiK0P0fQomCEv3Nj0MEa0gtaaBHFDmDWEaNeAoOugSXGyjSlAjMi4ydC6mDZ0G8YFigA31i2eF08700d4sXsfF1efPv64-DK__Pb568X55bzhJU1zimvBhOq4UKZjlBBRtczghklFWwUVJYbXQspOkVoArYkRMj-mZmXTYqbocfFh6zuMdY7dgEvB9HoIdmXCnfbG6n8VZ6_1wq91KQSvSpwN3u4Mgr8dISa9srGBvjcO_Bi1oJRKwdhEvnuUJJIISSVXE3ryAF36Mbh8ELrEhCouSJWh139Hv8_85zIzcLYFmuBjDNDtEaynuuipLnpflzzBHkw0Nm3KkP_d9o_MoV2USdjvwnXFch7CZUbe_wfR3dj3CX6mzL7assuYq3YPlyxfGOEk62-2eme8Notgo776Ph0MJgKXEjP6GyXZ8T8 |
CitedBy_id | crossref_primary_10_1016_j_tibs_2013_03_003 crossref_primary_10_1038_npp_2017_120 crossref_primary_10_3389_fphar_2021_775317 crossref_primary_10_1016_j_bbr_2017_12_010 crossref_primary_10_1111_cns_14520 crossref_primary_10_1021_acsptsci_0c00066 crossref_primary_10_3389_fncel_2016_00045 crossref_primary_10_1016_j_pbb_2023_173620 crossref_primary_10_1016_j_bbr_2015_05_053 crossref_primary_10_1074_jbc_M112_381368 crossref_primary_10_1126_scisignal_aai8441 crossref_primary_10_1111_j_1369_1600_2012_00494_x crossref_primary_10_1007_s40429_025_00618_x crossref_primary_10_1016_j_jchemneu_2013_04_003 crossref_primary_10_1016_j_celrep_2016_02_069 crossref_primary_10_1038_npp_2017_133 crossref_primary_10_3390_molecules28124848 crossref_primary_10_1074_jbc_M113_476234 crossref_primary_10_1016_j_pbb_2011_11_005 crossref_primary_10_1111_ejn_12490 crossref_primary_10_1016_j_tins_2012_11_002 crossref_primary_10_1016_j_neuron_2012_12_034 crossref_primary_10_1016_j_biopsych_2013_03_014 crossref_primary_10_1172_JCI97854 crossref_primary_10_1038_s41586_021_04013_0 crossref_primary_10_1016_j_brainres_2020_146742 crossref_primary_10_3389_fncel_2016_00061 crossref_primary_10_1039_D0NP00028K crossref_primary_10_1016_j_neuron_2019_02_029 crossref_primary_10_1021_acs_jmedchem_4c00736 crossref_primary_10_1111_bph_14913 crossref_primary_10_1371_journal_pone_0097216 crossref_primary_10_1007_s00213_020_05652_3 crossref_primary_10_1016_j_ejphar_2018_01_052 crossref_primary_10_3389_fnbeh_2020_00033 crossref_primary_10_1007_s00213_010_1806_y crossref_primary_10_1016_j_burns_2019_03_028 crossref_primary_10_1016_j_neuroscience_2016_01_052 crossref_primary_10_1016_j_neuron_2022_09_024 crossref_primary_10_3389_fnbeh_2022_836996 crossref_primary_10_1016_j_brainres_2018_09_023 crossref_primary_10_1155_2013_697632 crossref_primary_10_1016_j_alcohol_2011_10_006 crossref_primary_10_1016_j_biopsych_2011_11_015 crossref_primary_10_1016_j_neuropharm_2015_07_001 crossref_primary_10_1213_ANE_0000000000005309 crossref_primary_10_2139_ssrn_4168314 crossref_primary_10_1523_JNEUROSCI_3220_12_2012 crossref_primary_10_1093_alcalc_agw098 crossref_primary_10_1038_nrd_2017_229 crossref_primary_10_1016_j_physbeh_2012_01_003 crossref_primary_10_3389_fphar_2018_01388 crossref_primary_10_1016_j_neuropharm_2024_110061 crossref_primary_10_3389_fpsyt_2014_00170 crossref_primary_10_1523_JNEUROSCI_2053_12_2012 crossref_primary_10_1038_npp_2012_229 crossref_primary_10_1111_acer_12416 crossref_primary_10_1001_jamapsychiatry_2014_1221 crossref_primary_10_1038_npp_2013_261 crossref_primary_10_1038_s41421_018_0060_z crossref_primary_10_1016_j_jpsychires_2015_04_019 crossref_primary_10_1021_acs_jmedchem_3c00064 crossref_primary_10_1016_j_neuropharm_2018_07_034 crossref_primary_10_1016_j_bmc_2017_06_035 crossref_primary_10_1016_j_bbr_2018_05_011 crossref_primary_10_1016_j_neuropharm_2021_108769 crossref_primary_10_1007_s00213_012_2864_0 crossref_primary_10_1016_j_ntt_2021_107033 crossref_primary_10_1038_npp_2013_151 crossref_primary_10_1523_ENEURO_0028_20_2020 crossref_primary_10_1016_j_ynpai_2023_100121 crossref_primary_10_1111_jnc_15340 crossref_primary_10_1007_s00018_011_0844_x crossref_primary_10_1124_jpet_112_193615 crossref_primary_10_1016_j_alcohol_2017_01_001 crossref_primary_10_1038_aps_2015_32 crossref_primary_10_1016_j_npep_2010_12_004 crossref_primary_10_1111_j_1476_5381_2012_02075_x crossref_primary_10_1016_j_bbr_2014_02_029 crossref_primary_10_1111_ejn_14127 crossref_primary_10_1016_j_euroneuro_2015_11_009 crossref_primary_10_1016_j_phrs_2022_106091 crossref_primary_10_1111_acer_13406 crossref_primary_10_1016_j_bbr_2017_03_033 crossref_primary_10_1111_adb_12392 crossref_primary_10_1038_s41583_018_0028_x crossref_primary_10_1172_JCI90678 crossref_primary_10_1111_j_1369_1600_2012_00455_x crossref_primary_10_1038_npp_2010_67 crossref_primary_10_1073_pnas_1205565109 crossref_primary_10_1016_j_ejphar_2015_05_012 crossref_primary_10_7554_eLife_55523 crossref_primary_10_1016_j_pharmthera_2019_04_009 crossref_primary_10_1016_j_pnpbp_2019_02_010 crossref_primary_10_1038_s41386_021_01178_0 crossref_primary_10_1074_jbc_M112_405696 crossref_primary_10_3389_fnins_2015_00466 crossref_primary_10_1038_s41386_019_0423_7 crossref_primary_10_1111_bph_13854 crossref_primary_10_1007_s00213_016_4484_6 crossref_primary_10_1016_j_phrs_2023_106961 crossref_primary_10_1111_adb_12020 crossref_primary_10_1016_j_neuint_2019_104504 crossref_primary_10_1016_j_neuropharm_2019_02_010 crossref_primary_10_1016_j_ynstr_2021_100364 crossref_primary_10_1021_acschemneuro_5b00092 crossref_primary_10_1016_j_cellsig_2017_01_016 crossref_primary_10_1038_s41467_019_12316_0 crossref_primary_10_1111_adb_12133 crossref_primary_10_1016_j_neuropharm_2016_04_022 crossref_primary_10_1124_jpet_118_255661 crossref_primary_10_1016_j_neuropharm_2011_02_012 crossref_primary_10_1124_mol_111_074195 crossref_primary_10_1016_j_pbb_2015_05_008 crossref_primary_10_1016_j_conb_2013_02_005 crossref_primary_10_1124_pr_114_009209 crossref_primary_10_3389_fncel_2022_807549 crossref_primary_10_1111_ejn_15926 crossref_primary_10_1016_j_neuron_2019_03_003 crossref_primary_10_1517_13543784_2015_1020109 crossref_primary_10_3390_ijms21144833 crossref_primary_10_1016_j_neuron_2011_07_018 crossref_primary_10_1016_j_physbeh_2016_02_024 crossref_primary_10_1016_j_ejphar_2014_11_044 crossref_primary_10_1016_j_neuroscience_2014_11_053 crossref_primary_10_3389_fnins_2021_642493 crossref_primary_10_1038_s41401_022_00987_3 crossref_primary_10_1111_bph_13873 crossref_primary_10_1523_ENEURO_0043_23_2023 crossref_primary_10_1007_s00213_010_1825_8 crossref_primary_10_1126_scisignal_aba0245 crossref_primary_10_7554_eLife_68130 crossref_primary_10_1016_j_cobeha_2019_01_002 crossref_primary_10_3389_fphar_2019_00407 crossref_primary_10_1016_j_neuroscience_2012_07_040 crossref_primary_10_1016_j_ynstr_2018_08_003 crossref_primary_10_1111_apha_13882 crossref_primary_10_1111_bph_12692 crossref_primary_10_1176_appi_focus_10_4_452 crossref_primary_10_3390_molecules27207065 crossref_primary_10_1016_j_neuropharm_2013_09_021 crossref_primary_10_1016_j_pnpbp_2015_01_001 crossref_primary_10_1146_annurev_pharmtox_010919_023317 crossref_primary_10_1007_s10571_013_0011_z crossref_primary_10_3389_fpsyt_2017_00052 crossref_primary_10_1016_j_biopsych_2011_05_021 crossref_primary_10_1038_npp_2013_171 crossref_primary_10_1073_pnas_1521825113 crossref_primary_10_1146_annurev_neuro_080317_061522 crossref_primary_10_1021_ci400019t crossref_primary_10_1074_jbc_C112_387332 crossref_primary_10_1007_s00213_013_3182_x crossref_primary_10_1007_s10309_011_0218_2 crossref_primary_10_1016_j_pnpbp_2016_07_008 crossref_primary_10_1016_j_neuropharm_2018_11_011 crossref_primary_10_3389_fnbeh_2020_582147 crossref_primary_10_3389_fnins_2025_1507747 crossref_primary_10_1016_j_neuropharm_2018_11_010 crossref_primary_10_1016_j_peptides_2010_09_016 crossref_primary_10_1007_s11916_014_0410_y crossref_primary_10_1016_j_tins_2021_09_004 crossref_primary_10_1016_j_pnpbp_2022_110599 crossref_primary_10_1007_s11055_016_0288_8 crossref_primary_10_3390_molecules26164767 crossref_primary_10_1016_j_neuropharm_2013_05_024 crossref_primary_10_1021_acschemneuro_6b00268 crossref_primary_10_1038_mp_2011_119 crossref_primary_10_1016_j_neuron_2011_06_011 crossref_primary_10_1016_j_alcohol_2012_05_004 crossref_primary_10_1038_npp_2015_268 crossref_primary_10_1016_j_neubiorev_2018_09_008 crossref_primary_10_1021_acs_jmedchem_6b01418 crossref_primary_10_1016_j_neuropharm_2019_01_017 crossref_primary_10_1016_j_cub_2021_07_047 crossref_primary_10_1038_npp_2015_142 crossref_primary_10_1016_j_pnpbp_2015_06_006 crossref_primary_10_3390_biomedicines9121882 crossref_primary_10_1016_j_conb_2013_03_011 crossref_primary_10_1371_journal_pone_0206421 crossref_primary_10_1016_j_neuron_2015_08_019 crossref_primary_10_1016_j_yfrne_2018_05_003 crossref_primary_10_1523_JNEUROSCI_1979_13_2013 crossref_primary_10_1523_JNEUROSCI_2838_13_2014 crossref_primary_10_1016_j_pbb_2022_173377 crossref_primary_10_1124_mol_113_089649 crossref_primary_10_1111_bph_14088 crossref_primary_10_3389_fphar_2014_00253 crossref_primary_10_1007_s00213_010_1846_3 crossref_primary_10_1016_j_ejphar_2015_07_018 crossref_primary_10_1176_appi_ajp_2020_20081224 crossref_primary_10_1016_j_biopsych_2014_04_019 crossref_primary_10_1007_s00213_017_4637_2 crossref_primary_10_1021_acs_biochem_0c00629 crossref_primary_10_3389_fnins_2022_964724 crossref_primary_10_1074_jbc_RA119_009592 crossref_primary_10_7554_eLife_23785 crossref_primary_10_1016_j_pbb_2012_10_009 crossref_primary_10_1113_JP271657 crossref_primary_10_1002_jnr_23815 crossref_primary_10_1007_s00213_013_3195_5 crossref_primary_10_1016_j_ynstr_2022_100493 crossref_primary_10_1007_s00259_019_04488_0 crossref_primary_10_3389_fphar_2022_856672 crossref_primary_10_1007_s40429_021_00361_z crossref_primary_10_1016_j_cellsig_2015_03_026 crossref_primary_10_1016_j_psyneuen_2011_10_002 crossref_primary_10_1038_s41380_023_02204_x crossref_primary_10_1002_dev_21192 crossref_primary_10_1016_j_addicn_2022_100005 crossref_primary_10_3390_ijms20164010 |
Cites_doi | 10.1038/nrn1406 10.1038/nature03694 10.1038/nn1399 10.1038/nature04172 10.1038/npp.2008.142 10.1016/j.ejphar.2007.05.007 10.1073/pnas.0501432102 10.1016/j.neuron.2008.06.012 10.1016/0014-2999(88)90803-5 10.1073/pnas.0600084103 10.1523/JNEUROSCI.22-24-10856.2002 10.1111/j.1471-4159.2004.02589.x 10.1124/jpet.102.037861 10.1007/s00213-005-0167-4 10.1523/JNEUROSCI.3769-07.2007 10.1038/sj.npp.1300872 10.1073/pnas.091039298 10.1126/science.3016896 10.1073/pnas.0603081103 10.1074/jbc.M705540200 10.1038/sj.npp.1301438 10.1523/JNEUROSCI.23-31-09981.2003 10.1006/mthe.2001.0282 10.1073/pnas.0705740104 10.1038/nn1123 10.1515/REVNEURO.1995.6.3.279 10.1016/S0896-6273(02)00653-0 10.1016/S0006-8993(00)02776-1 10.1523/JNEUROSCI.3133-07.2007 10.1523/JNEUROSCI.22-18-07844.2002 10.1128/JVI.72.12.9873-9880.1998 10.1038/88115 10.1523/JNEUROSCI.4458-07.2008 10.1074/jbc.M513640200 10.1046/j.1471-4159.1998.70020635.x 10.1038/nrn1346 10.1038/nrn1539 10.1074/jbc.M304022200 10.1523/JNEUROSCI.22-16-07308.2002 10.1523/JNEUROSCI.23-13-05674.2003 10.1038/nature07455 10.1007/s00213-008-1122-y 10.1016/0006-8993(87)91571-X |
ContentType | Journal Article |
Copyright | Copyright National Academy of Sciences Nov 10, 2009 |
Copyright_xml | – notice: Copyright National Academy of Sciences Nov 10, 2009 |
DBID | FBQ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QG 7QL 7QP 7QR 7SN 7SS 7T5 7TK 7TM 7TO 7U9 8FD C1K FR3 H94 M7N P64 RC3 7S9 L.6 7X8 5PM |
DOI | 10.1073/pnas.0910705106 |
DatabaseName | AGRIS CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts Ecology Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Entomology Abstracts Genetics Abstracts Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitleList | AGRICOLA Virology and AIDS Abstracts MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
EISSN | 1091-6490 |
EndPage | 19173 |
ExternalDocumentID | PMC2776420 1900726761 19864633 10_1073_pnas_0910705106 106_45_19168 25593161 US201301702805 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural Feature |
GrantInformation_xml | – fundername: NIDA NIH HHS grantid: DA16898 – fundername: NIDA NIH HHS grantid: K99 DA025182 – fundername: NIDA NIH HHS grantid: R01 DA016898 – fundername: Howard Hughes Medical Institute – fundername: NIDA NIH HHS grantid: DA25182 – fundername: NIDA NIH HHS grantid: DA20570 – fundername: NIDA NIH HHS grantid: R00 DA025182 – fundername: NIDA NIH HHS grantid: R21 DA025970 – fundername: NIDA NIH HHS grantid: K05 DA020570 |
GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 123 29P 2AX 2FS 2WC 3O- 4.4 53G 5RE 5VS 692 6TJ 79B 85S AACGO AAFWJ AANCE AAYJJ ABBHK ABOCM ABPLY ABPPZ ABPTK ABTLG ABZEH ACGOD ACIWK ACKIV ACNCT ACPRK ADULT ADZLD AENEX AEUPB AEXZC AFDAS AFFNX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS ASUFR AS~ BKOMP CS3 D0L DCCCD DIK DNJUQ DOOOF DU5 DWIUU E3Z EBS EJD F20 F5P FBQ FRP GX1 HGD HH5 HQ3 HTVGU HYE JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JSODD JST KQ8 L7B LU7 MVM N9A NEJ NHB N~3 O9- OK1 P-O PNE PQQKQ R.V RHF RHI RNA RNS RPM RXW SA0 SJN TAE TN5 UKR VOH VQA W8F WH7 WHG WOQ WOW X7M XFK XSW Y6R YBH YKV YSK ZA5 ZCA ZCG ~02 ~KM ABXSQ ACHIC ADQXQ ADXHL AQVQM H13 IPSME - 02 0R 1AW 55 AAPBV ABFLS ADACO AJYGW AS DZ KM PQEST X XHC AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QG 7QL 7QP 7QR 7SN 7SS 7T5 7TK 7TM 7TO 7U9 8FD C1K FR3 H94 M7N P64 RC3 7S9 L.6 7X8 5PM |
ID | FETCH-LOGICAL-c623t-30b7579f679af531174d5a0c5893d9e431a6b788f91b7e3b1a781a7ab52cd0593 |
ISSN | 0027-8424 1091-6490 |
IngestDate | Thu Aug 21 14:07:02 EDT 2025 Fri Sep 05 14:23:29 EDT 2025 Fri Sep 05 04:45:46 EDT 2025 Sat Aug 23 13:14:27 EDT 2025 Sat May 31 02:11:10 EDT 2025 Tue Jul 01 00:46:46 EDT 2025 Thu Apr 24 23:10:07 EDT 2025 Thu May 30 08:49:31 EDT 2019 Wed Nov 11 00:29:25 EST 2020 Thu May 29 08:43:02 EDT 2025 Wed Dec 27 19:05:39 EST 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 45 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c623t-30b7579f679af531174d5a0c5893d9e431a6b788f91b7e3b1a781a7ab52cd0593 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 Author contributions: B.B.L., M.R.B., R.D.P., and C.C. designed research; B.B.L., M.R.B., W.J.G., M.A., and D.M. performed research; S.S., T.S.H., and R.D.P. contributed new reagents/analytic tools; B.B.L., M.R.B., T.S.H., and C.C. analyzed data; and B.B.L., M.R.B., and C.C. wrote the paper. Contributed by Richard D. Palmiter, September 23, 2009 1B.B.L. and M.R.B. contributed equally to this work. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/2776420 |
PMID | 19864633 |
PQID | 201396714 |
PQPubID | 42026 |
PageCount | 6 |
ParticipantIDs | crossref_citationtrail_10_1073_pnas_0910705106 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2776420 fao_agris_US201301702805 proquest_miscellaneous_733387550 jstor_primary_25593161 crossref_primary_10_1073_pnas_0910705106 pnas_primary_106_45_19168 proquest_journals_201396714 pubmed_primary_19864633 proquest_miscellaneous_1817838690 pnas_primary_106_45_19168_fulltext |
ProviderPackageCode | RNA PNE CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-11-10 |
PublicationDateYYYYMMDD | 2009-11-10 |
PublicationDate_xml | – month: 11 year: 2009 text: 2009-11-10 day: 10 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Washington |
PublicationTitle | Proceedings of the National Academy of Sciences - PNAS |
PublicationTitleAlternate | Proc Natl Acad Sci U S A |
PublicationYear | 2009 |
Publisher | National Academy of Sciences National Acad Sciences |
Publisher_xml | – name: National Academy of Sciences – name: National Acad Sciences |
References | e_1_3_3_17_2 e_1_3_3_38_2 e_1_3_3_18_2 e_1_3_3_39_2 e_1_3_3_13_2 e_1_3_3_36_2 e_1_3_3_12_2 e_1_3_3_37_2 e_1_3_3_15_2 e_1_3_3_34_2 e_1_3_3_14_2 e_1_3_3_35_2 e_1_3_3_32_2 e_1_3_3_33_2 e_1_3_3_11_2 e_1_3_3_30_2 e_1_3_3_10_2 e_1_3_3_31_2 Horan P (e_1_3_3_19_2) 1992; 260 Shippenberg TS (e_1_3_3_40_2) 1986; 75 e_1_3_3_6_2 e_1_3_3_5_2 e_1_3_3_8_2 e_1_3_3_7_2 e_1_3_3_28_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_24_2 e_1_3_3_23_2 e_1_3_3_26_2 e_1_3_3_45_2 Bals-Kubik R (e_1_3_3_16_2) 1993; 264 e_1_3_3_25_2 e_1_3_3_46_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_43_2 e_1_3_3_1_2 e_1_3_3_44_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_41_2 e_1_3_3_3_2 e_1_3_3_21_2 e_1_3_3_42_2 |
References_xml | – ident: e_1_3_3_11_2 doi: 10.1038/nrn1406 – ident: e_1_3_3_22_2 doi: 10.1038/nature03694 – ident: e_1_3_3_14_2 doi: 10.1038/nn1399 – ident: e_1_3_3_12_2 doi: 10.1038/nature04172 – ident: e_1_3_3_41_2 doi: 10.1038/npp.2008.142 – ident: e_1_3_3_7_2 doi: 10.1016/j.ejphar.2007.05.007 – ident: e_1_3_3_36_2 doi: 10.1073/pnas.0501432102 – ident: e_1_3_3_10_2 doi: 10.1016/j.neuron.2008.06.012 – ident: e_1_3_3_35_2 doi: 10.1016/0014-2999(88)90803-5 – ident: e_1_3_3_38_2 doi: 10.1073/pnas.0600084103 – ident: e_1_3_3_30_2 doi: 10.1523/JNEUROSCI.22-24-10856.2002 – ident: e_1_3_3_28_2 doi: 10.1111/j.1471-4159.2004.02589.x – ident: e_1_3_3_32_2 doi: 10.1124/jpet.102.037861 – ident: e_1_3_3_9_2 doi: 10.1007/s00213-005-0167-4 – ident: e_1_3_3_25_2 doi: 10.1523/JNEUROSCI.3769-07.2007 – ident: e_1_3_3_8_2 doi: 10.1038/sj.npp.1300872 – ident: e_1_3_3_29_2 doi: 10.1073/pnas.091039298 – ident: e_1_3_3_39_2 doi: 10.1126/science.3016896 – ident: e_1_3_3_18_2 doi: 10.1073/pnas.0603081103 – ident: e_1_3_3_20_2 doi: 10.1074/jbc.M705540200 – volume: 264 start-page: 489 year: 1993 ident: e_1_3_3_16_2 article-title: Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats publication-title: J Pharmacol Exp Ther – ident: e_1_3_3_43_2 doi: 10.1038/sj.npp.1301438 – ident: e_1_3_3_17_2 doi: 10.1523/JNEUROSCI.23-31-09981.2003 – ident: e_1_3_3_44_2 doi: 10.1006/mthe.2001.0282 – ident: e_1_3_3_15_2 doi: 10.1073/pnas.0705740104 – volume: 75 start-page: 563 year: 1986 ident: e_1_3_3_40_2 article-title: Differential effects of mu and kappa opioid systems on motivational processes publication-title: NIDA Res Monogr – ident: e_1_3_3_4_2 doi: 10.1038/nn1123 – ident: e_1_3_3_33_2 doi: 10.1515/REVNEURO.1995.6.3.279 – volume: 260 start-page: 1237 year: 1992 ident: e_1_3_3_19_2 article-title: Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test publication-title: J Pharmacol Exp Ther – ident: e_1_3_3_2_2 doi: 10.1016/S0896-6273(02)00653-0 – ident: e_1_3_3_23_2 doi: 10.1016/S0006-8993(00)02776-1 – ident: e_1_3_3_13_2 doi: 10.1523/JNEUROSCI.3133-07.2007 – ident: e_1_3_3_31_2 doi: 10.1523/JNEUROSCI.22-18-07844.2002 – ident: e_1_3_3_45_2 doi: 10.1128/JVI.72.12.9873-9880.1998 – ident: e_1_3_3_46_2 doi: 10.1038/88115 – ident: e_1_3_3_5_2 doi: 10.1523/JNEUROSCI.4458-07.2008 – ident: e_1_3_3_24_2 doi: 10.1074/jbc.M513640200 – ident: e_1_3_3_26_2 doi: 10.1046/j.1471-4159.1998.70020635.x – ident: e_1_3_3_37_2 doi: 10.1038/nrn1346 – ident: e_1_3_3_3_2 doi: 10.1038/nrn1539 – ident: e_1_3_3_21_2 doi: 10.1074/jbc.M304022200 – ident: e_1_3_3_27_2 doi: 10.1523/JNEUROSCI.22-16-07308.2002 – ident: e_1_3_3_42_2 doi: 10.1523/JNEUROSCI.23-13-05674.2003 – ident: e_1_3_3_1_2 doi: 10.1038/nature07455 – ident: e_1_3_3_6_2 doi: 10.1007/s00213-008-1122-y – ident: e_1_3_3_34_2 doi: 10.1016/0006-8993(87)91571-X |
SSID | ssj0009580 |
Score | 2.448122 |
Snippet | Although stress has profound effects on motivated behavior, the underlying mechanisms responsible are incompletely understood. In this study we elucidate a... |
SourceID | pubmedcentral proquest pubmed crossref pnas jstor fao |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 19168 |
SubjectTerms | 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer - pharmacology Agonists Analysis of Variance Animal behavior Animals antagonists Behavioral neuroscience Biological Sciences Brain Cocaine Cocaine - metabolism dopamine drugs Effects Enzyme-Linked Immunosorbent Assay Immunohistochemistry Inactivation Lentivirus Male Mice Mice, Inbred C57BL Mice, Knockout mitogen-activated protein kinase Mutation Naltrexone - analogs & derivatives Naltrexone - pharmacology Neurons Opioid analgesics Opioid receptors Raphe Nuclei - metabolism Receptors Receptors, Opioid, kappa - agonists Receptors, Opioid, kappa - antagonists & inhibitors Receptors, Opioid, kappa - genetics Receptors, Opioid, kappa - metabolism relapse Rodents Serotonin agents Stress Stress, Physiological - genetics Stress, Physiological - physiology Studies T tests Ventral Tegmental Area - metabolism |
Title | Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking |
URI | https://www.jstor.org/stable/25593161 http://www.pnas.org/content/106/45/19168.abstract https://www.ncbi.nlm.nih.gov/pubmed/19864633 https://www.proquest.com/docview/201396714 https://www.proquest.com/docview/1817838690 https://www.proquest.com/docview/733387550 https://pubmed.ncbi.nlm.nih.gov/PMC2776420 |
Volume | 106 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLa6ccMNYsBYGCCDuBiKUtI4iZPLDgHTBNXENml3kZM4WxkkVdNwwQvwsjwE5zh20latNJDaqI1PXbfny_lxzg8hb2QqRJrH3JEych0_96UjojQHr9XNGctCPvIwOfnLJDy59E-vgqvB4M9S1FKzSIfZr415Jf_DVTgHfMUs2X_gbDcpnIDXwF84AofheCcejzPTnMzc6r8Vs5mwq9m0mmJaCsasqIBzNZhX8xrr-IsZvCmxkHFTt6kjuPmKFEIFafxcCfPQ2SQqDl1OS5WBVNv5vLm2aylvjerTBu5ZpxBrs6aJ2W8c99krWqTUtmOfTfpeyJ91mOWxLL-JH7Ds42G_X9BkOvtMh_rbX7vBczixWIhGdxFDVdqpm09TvAhUh3FTg8I-Ha7sdsSOirhbluAeaFW_zbseylZog83jhH7bdrST6m64BF8_WBLS4KK2rXy0xkeXlW1UJyD_sAdyKeoh2lUcJdiGwt1rCrULc1Q3-DlLcIKkn2CH3PM4WHpmb6krER21CVP6F5pCVJy9W1vBig21U4jKBNNihV4g3eQtrQf9LllRFw_JA-3-0HGL5T0ykOUjsmfQQI90FfS3j8nvHty0KigAiSpw0xbc1ICbTks12IKbKnBTDW5qwK0oDLipBjdO24KbAuxoD26K4KYa3E_I5ccPF-9PHN01xMnAlF84zE15wOMi5LEoQMOAy50Hws0CsMzzWILBLMKUR1ERj1IuWToSPIKnSAMvy7HB5T7ZLatSHhDqsZyFMAYuQ-xHsQcPmeeZGwIlA8BZZGj4kGS6pD52dvmebOG8RY66D8zaajLbSQ-AsYm4Bl2fXJ57GGEw4hgIEVhkX3G7mwK3BRi4bhax1Cz91GHiB4nCu0Vebx1LCh1oZpFDA5xEy7k6wa-OQWj7FnnVjYISwjuLopRVUyfgJvCIYXM7i9AtNJwxFvEgAJKnLRL7tWCPiJAxi_AVjHYEWAN_daSc3qha-B7noe-5z-7-xx6S-71geU52F_NGvgDHYpG-VNfjX3j1I3M |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Activation+of+the+kappa+opioid+receptor+in+the+dorsal+raphe+nucleus+mediates+the+aversive+effects+of+stress+and+reinstates+drug+seeking&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Land%2C+Benjamin+B.&rft.au=Bruchas%2C+Michael+R.&rft.au=Schattauer%2C+Selena&rft.au=Giardino%2C+William+J.&rft.date=2009-11-10&rft.issn=0027-8424&rft.eissn=1091-6490&rft.volume=106&rft.issue=45&rft.spage=19168&rft.epage=19173&rft_id=info:doi/10.1073%2Fpnas.0910705106&rft.externalDBID=n%2Fa&rft.externalDocID=10_1073_pnas_0910705106 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F106%2F45.cover.gif |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F106%2F45.cover.gif |